🇺🇸 FDA
Patent

US 10189872

Crystalline form of nicotinamide riboside

granted A61KA61K31/706A61P

Quick answer

US patent 10189872 (Crystalline form of nicotinamide riboside) held by W.R. Grace & Co.-Conn. expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
W.R. Grace & Co.-Conn.
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/706, A61P, A61P25/28, A61P3/00